LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 10 of total 34

Search options

  1. Article ; Online: A cross-case analysis of developing program sustainability and institutionalization in early stages of a multisite biomedical student diversity initiative.

    Cobian, Krystle Palma / Ramos, Hector V

    BMC medical education

    2021  Volume 21, Issue 1, Page(s) 254

    Abstract: Background: Grant funding often drives innovative programming in efforts to enhance diversity in biomedical fields, yet strategies for sustainability of grant-funded biomedical intervention are not well understood. Additionally, as funding agencies ... ...

    Abstract Background: Grant funding often drives innovative programming in efforts to enhance diversity in biomedical fields, yet strategies for sustainability of grant-funded biomedical intervention are not well understood. Additionally, as funding agencies shift toward supporting institutional change to biomedical training, less is known about the extent to which sustainability strategies can support long-term institutionalization of the original goals of the grant-funded initiative. The purpose of this study is twofold: to identify strategies used by grant-funded programs for promoting sustainability, and to examine the interrelations between the concepts of sustainability and institutionalization during early stages of grant-funded biomedical career training efforts.
    Methods: We employed a multiple case study design and cross-case analysis using interviews of program administrators and participants from 10 undergraduate institutions that received Building Infrastructure Leading to Diversity (BUILD) awards funded by the National Institutes of Health (NIH).
    Results: BUILD sites engaged in the following strategies to develop program sustainability: 1) scaling and adapting to expand programmatic impact, 2) identifying additional funding and cost-cutting measures, 3) developing and maintaining infrastructure and structural operations, 4) leveraging relationships and with intra-and inter-institutional partners, and 5) and addressing hiring, policies, and reward systems at the institution. Senior administrative support supported program sustainability and early institutionalization, although we also identified situations where participants felt that they were on track for sustainable changes without administrative support or institutional change. Of the strategies identified, those that involve organizational and infrastructural changes contribute to early stages of institutionalization.
    Conclusions: This study contributes to literature on organizational change by providing evidence of distinctions and interrelations between program sustainability efforts and institutionalization of change efforts in that some sustainability strategies can overlap with strategies to move toward institutionalization. The findings indicate the importance of program administrators developing early sustainability plans that also lead to institutionalization, as well as an opportunity for funding agencies to develop technical assistance on sustainability, organizational change, and institutionalization as a resource to support program administrators' efforts toward making lasting, structural change on their campuses.
    MeSH term(s) Administrative Personnel ; Humans ; Institutionalization ; Organizational Innovation ; Program Evaluation ; Students
    Language English
    Publishing date 2021-05-03
    Publishing country England
    Document type Journal Article
    ZDB-ID 2044473-4
    ISSN 1472-6920 ; 1472-6920
    ISSN (online) 1472-6920
    ISSN 1472-6920
    DOI 10.1186/s12909-021-02663-2
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  2. Article ; Online: Investigating the relationship between participation in the building infrastructure leading to diversity (BUILD) initiative and intent to pursue a science career: A cross-sectional analysis.

    Ramos, Hector V / Cobian, Krystle P / Srinivasan, Jayashri / Christie, Christina A / Crespi, Catherine M / Seeman, Teresa

    Evaluation and program planning

    2023  Volume 102, Page(s) 102380

    Abstract: This paper presents an analysis of survey data to examine the association between supervised structured mentoring and students' intent to pursue a career in science. Data were collected from students in the 10 Building Infrastructure Leading to Diversity ...

    Abstract This paper presents an analysis of survey data to examine the association between supervised structured mentoring and students' intent to pursue a career in science. Data were collected from students in the 10 Building Infrastructure Leading to Diversity (BUILD) research training programs, developed through grants from the National Institutes of Health. Propensity score matching and multinomial logistic regression demonstrated that exposure to BUILD programs-meaning participation in undergraduate research, receipt of mentoring from a primary mentor, and/or participation as a funded scholar and/or associate of each BUILD site's training program-was associated with increased intent to pursue a science career. These findings have implications for STEM program evaluation and practice in higher education.
    MeSH term(s) Humans ; Cross-Sectional Studies ; Program Evaluation ; Minority Groups/education ; Mentors ; Mentoring
    Language English
    Publishing date 2023-10-12
    Publishing country England
    Document type Journal Article
    ZDB-ID 2013444-7
    ISSN 1873-7870 ; 0149-7189
    ISSN (online) 1873-7870
    ISSN 0149-7189
    DOI 10.1016/j.evalprogplan.2023.102380
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  3. Article: Implementing case study design to evaluate diverse institutions and STEM education contexts: Lessons and key areas for systematic study.

    Cobian, Krystle P / White-Lewis, Damani Khary / Hurtado, Sylvia / Ramos, Hector V

    New directions for evaluation

    2022  Volume 2022, Issue 174, Page(s) 21–31

    Abstract: This chapter highlights the important contributions of case study research to the evaluation of student-centered programs and broader STEM initiatives in higher education. We summarize the Diversity Program Consortium's case study evaluation of the ... ...

    Abstract This chapter highlights the important contributions of case study research to the evaluation of student-centered programs and broader STEM initiatives in higher education. We summarize the Diversity Program Consortium's case study evaluation of the Building Infrastructure Leading to Diversity (BUILD) initiative, funded by the National Institutes of Health (NIH), with aims to enhance diversity in the NIH-funded workforce. We describe lessons learned from the case study design used for the evaluation of BUILD that applies to administrators of STEM initiatives who are interested in case study methods and to evaluators who are familiar with case studies and tasked with program evaluation of a multisite STEM program. These lessons include practical considerations for logistics and the importance of clarifying the goals of the case study design within the larger program evaluation, fostering the continuation of knowledge within the evaluation team, and embedding trust building and collaboration throughout all stages of the case study.
    Language English
    Publishing date 2022-08-08
    Publishing country United States
    Document type Journal Article
    ZDB-ID 2060755-6
    ISSN 1534-875X ; 1097-6736
    ISSN (online) 1534-875X
    ISSN 1097-6736
    DOI 10.1002/ev.20507
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  4. Article ; Online: Laboratory information management software for engineered mini-protein therapeutic workflow.

    Brusniak, Mi-Youn / Ramos, Hector / Lee, Bernard / Olson, James M

    BMC bioinformatics

    2019  Volume 20, Issue 1, Page(s) 343

    Abstract: Background: Protein based therapeutics are one of the fastest growing classes of novel medical interventions in areas such as cancer, infectious disease, and inflammation. Protein engineering plays an important role in the optimization of desired ... ...

    Abstract Background: Protein based therapeutics are one of the fastest growing classes of novel medical interventions in areas such as cancer, infectious disease, and inflammation. Protein engineering plays an important role in the optimization of desired therapeutic properties such as reducing immunogenicity, increasing stability for storage, increasing target specificity, etc. One category of protein therapeutics is nature-inspired bioengineered cystine-dense peptides (CDPs) for various biological targets. These engineered proteins are often further modified by synthetic chemistry. For example, candidate mini-proteins can be conjugated into active small molecule drugs. We refer to modified mini-proteins as "Optides" (Optimized peptides). To efficiently serve the multidisciplinary lab scientists with varied therapeutic portfolio research goals in a non-commercial setting, a cost effective extendable laboratory information management system (LIMS) is/was needed.
    Results: We have developed a LIMS named Optide-Hunter for a generalized engineered protein compounds workflow that tracks entities and assays from creation to preclinical experiments. The implementation and custom modules are built using LabKey server, which is an Open Source platform for scientific data integration and analysis. Optide-Hunter contains a compound registry, in-silico assays, high throughput production, large-scale production, in vivo assays and data extraction from a specimen-tracking database. It is used to store, extract, and view data for various therapeutics projects. Optide-Hunter also includes external processing stand-alone software (HPLCPeakClassifierApp) for automated chromatogram classification. The HPLCPeakClassifierApp is used for pre-processing of HPLC data prior to loading to Optide-Hunter. The custom implementation is done using data transformation modules in R, SQL, javascript, and java and is Open Source to assist new users in customizing it for their unique workflows. Instructions for exploring a deployed version of Optide-Hunter can be found at https://www.labkey.com/case%20study/optide-hunter CONCLUSION: The Optide-Hunter LIMS system is designed and built to track the process of engineering, producing and prioritizing protein therapeutic candidates. It can be easily adapted and extended for use in small or large research laboratories where multidisciplinary scientists are collaborating to engineer compounds for potential therapeutic or protein science applications. Open Source exploration of Optide-Hunter can help any bioinformatics scientist adapt, extend, and deploy an equivalent system tailored to each laboratory's workflow.
    MeSH term(s) Automation ; Humans ; Information Management ; Laboratories ; Protein Engineering ; Proteins/therapeutic use ; Software ; User-Computer Interface ; Workflow
    Chemical Substances Proteins
    Language English
    Publishing date 2019-06-17
    Publishing country England
    Document type Journal Article
    ZDB-ID 2041484-5
    ISSN 1471-2105 ; 1471-2105
    ISSN (online) 1471-2105
    ISSN 1471-2105
    DOI 10.1186/s12859-019-2935-x
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  5. Article: Low-cost Method for Obtaining Medical Rapid Prototyping Using Desktop 3D printing: A Novel Technique for Mandibular Reconstruction Planning.

    Velasco, Ignacio / Vahdani, Soheil / Ramos, Hector

    Journal of clinical and experimental dentistry

    2017  Volume 9, Issue 9, Page(s) e1103–e1108

    Abstract: Background: Three-dimensional (3D) printing is relatively a new technology with clinical applications, which enable us to create rapid accurate prototype of the selected anatomic region, making it possible to plan complex surgery and pre-bend hardware ... ...

    Abstract Background: Three-dimensional (3D) printing is relatively a new technology with clinical applications, which enable us to create rapid accurate prototype of the selected anatomic region, making it possible to plan complex surgery and pre-bend hardware for individual surgical cases. This study aimed to express our experience with the use of medical rapid prototype (MRP) of the maxillofacial region created by desktop 3D printer and its application in maxillofacial reconstructive surgeries.
    Material and methods: Three patients with benign mandible tumors were included in this study after obtaining informed consent. All patient's maxillofacial CT scan data was processed by segmentation and isolation software and mandible MRP was printed using our desktop 3D printer. These models were used for preoperative surgical planning and prebending of the reconstruction plate.
    Conclusions: MRP created by desktop 3D printer is a cost-efficient, quick and easily produced appliance for the planning of reconstructive surgery. It can contribute in patient orientation and helping them in a better understanding of their condition and proposed surgical treatment. It helps surgeons for pre-operative planning in the resection or reconstruction cases and represent an excellent tool in academic setting for residents training. The pre-bended reconstruction plate based on MRP, resulted in decreased surgery time, cost and anesthesia risks on the patients.
    Language English
    Publishing date 2017-09-01
    Publishing country Spain
    Document type Journal Article
    ZDB-ID 2586647-3
    ISSN 1989-5488
    ISSN 1989-5488
    DOI 10.4317/jced.54055
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  6. Article: Culture as a driving force of individual and organizationel behavior

    Dubina, Igor N / Ramos, Hector / Ramos, Suzanna J

    Creativity, innovation, and entrepreneurship across cultures , p. 1-27

    2016  , Page(s) 1–27

    Author's details Igor N. Dubina, Suzanna J. Ramos, and Hector Ramos
    Language English
    Publisher Springer
    Publishing place New York
    Document type Article
    ISBN 1-4939-3260-8 ; 978-1-4939-3260-3
    Database ECONomics Information System

    More links

    Kategorien

  7. Article ; Online: Compatibility of prolonged infusion antibiotics during Y-site administration.

    Nunez-Nunez, María / Murillo-Izquierdo, Manuel / Moya-Martin, Marisa / Hoxha, Malvina / Quesada Pérez, M Teresa / Oltra-Hostalet, Fernando / Alonso-Ramos, Hector / Cordero-Ramos, Jaime / Barrera-Cabeza, Jose / Retamar-Gentil, Pilar / Fernández-Del-Castillo, Santiago Sandoval

    Nursing in critical care

    2022  Volume 27, Issue 6, Page(s) 849–858

    Abstract: Background: Antimicrobial resistance is a threat to global public health. The use of prolonged infusions in the hospital setting for certain antimicrobials is widely increasing in order to improve their efficacy and safety, including resistance ... ...

    Abstract Background: Antimicrobial resistance is a threat to global public health. The use of prolonged infusions in the hospital setting for certain antimicrobials is widely increasing in order to improve their efficacy and safety, including resistance development. Due to limited vascular access, it is important to clarify whether they can be infused through the same line with other drugs during Y-site administration.
    Aim: The aim of this review is to update and summarize the evidence on Y-site compatibility of antibacterial agents administered as prolonged infusions in intensive care units (ICUs).
    Study design: A literature review of PubMed, EMBASE and Trissel's Handbook on Injectable Drugs databases was conducted on the compatibility of selected antimicrobials administered simultaneously at a Y-site connection with parenteral nutrition and other widely used drugs in ICUs. All articles published up to October 30, 2021, in English or Spanish were included, regardless of the type of publication (original articles, case reports, letters, etc.). Eligible antimicrobials were those that can be administered as prolonged infusions: ceftazidime, cefepime, piperacillin/tazobactam, meropenem, ceftolozane/tazobactam, ceftaroline, cloxacillin, ceftobiprole, vancomycin and fosfomycin.
    Results: A total of 1302 drug-to-drug potential combinations were explored, 196 (15.05%) were found to be incompatible, and in 541 (41.55%), data were not available. The results were presented in a simple 2-dimensional consultation chart as a quick reference for health care professionals.
    Conclusions: This review provides useful and reliable information on the compatibility of antimicrobials administered as Y-site infusion with other drugs commonly used in the critical setting. This review contributes to patient safety in nursing practice.
    Relevance to clinical practice: To our knowledge, this is the first review on Y-site compatibility of antimicrobials used as prolonged infusions with other commonly used drugs, including anti-emetics, analgesics and anti-epileptic and parenteral nutrition. The results of the current review need to be addressed to promote the knowledge sharing between health professionals and improve the quality and safety of patients. We believe that this review may serve as a simple and effective 2-dimensional updated drug-to-drug compatibility reference chart for critical care nurses.
    MeSH term(s) Humans ; Anti-Bacterial Agents ; Infusions, Intravenous ; Meropenem ; Cefepime ; Tazobactam
    Chemical Substances Anti-Bacterial Agents ; Meropenem (FV9J3JU8B1) ; Cefepime (807PW4VQE3) ; Tazobactam (SE10G96M8W)
    Language English
    Publishing date 2022-01-27
    Publishing country England
    Document type Journal Article ; Review
    ZDB-ID 2011956-2
    ISSN 1478-5153 ; 1362-1017
    ISSN (online) 1478-5153
    ISSN 1362-1017
    DOI 10.1111/nicc.12754
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  8. Article ; Online: Pharmacist care in hospital emergency departments: a consensus paper from the Spanish hospital pharmacy and emergency medicine associations.

    Ruiz Ramos, Jesús / Calderón Hernanz, Beatriz / Castellanos Clemente, Yolanda / Bonete Sánchez, Manuel / Vallve Alcon, Emili / Santolaya Perrin, M ª Rosario / García Martín, M ª Ángeles / de Lorenzo Pinto, Ana / Real Campaña, José Manuel / Ramos Rodríguez, Javier / Calzón Blanco, Cristina / García Peláez, Milagros / Alonso Ramos, Héctor / Altimiras Ruiz, Joan / Sempere Serrano, Paloma / Martín Cerezuela, María / Periañez Parraga, Leonor / Juanes Borrego, Ana María / Somoza Fernández, Beatriz /
    Rodríguez Camacho, Juan Manuel / Puig Campmany, Mireia / Miguens Blanco, Iria / Tomás Vecina, Santiago / Nadal Galmes, Catalina / Povar Marco, Javier

    Emergencias : revista de la Sociedad Espanola de Medicina de Emergencias

    2023  Volume 35, Issue 3, Page(s) 205–217

    Abstract: Objectives: To draft a list of actions and quality indicators for pharmacist care in hospital emergency departments, based on consensus among a panel of experts regarding which actions to prioritize in this setting.: Material and methods: A panel of ... ...

    Title translation Atención farmacéutica en los servicios de urgencias: documento de posicionamiento de la Sociedad Española de Farmacia Hospitalaria (SEFH) y la Sociedad Española de Medicina de Urgencias y Emergencias (SEMES).
    Abstract Objectives: To draft a list of actions and quality indicators for pharmacist care in hospital emergency departments, based on consensus among a panel of experts regarding which actions to prioritize in this setting.
    Material and methods: A panel of experts from the Spanish Society of Hospital Pharmacy (SEFH) and the Spanish Society of Emergency Medicine (SEMES) evaluated a preliminary list of potential actions and quality of care indicators. The experts used a questionnaire to assess the proposals on the basis of available evidence. In the first round, each expert individually assessed the importance of each proposed action based on 4 dimensions: evidence base, impact on clinical response and patient safety, ease of implementation, and priority. In the second round the experts attended a virtual meeting to reach consensus on a revised list of proposals; suggestions and comments that had been made anonymously in the first round were included. The group then prioritized each action as basic, intermediate, or advanced.
    Results: The experts evaluated a total of 26 potential actions and associated quality indicators. No items were eliminated in the analysis of scores and comments from the first round. After the second round, 25 actions survived. Nine were considered basic, 10 intermediate, and 6 advanced.
    Conclusion: The expert panel's list of pharmacist actions and care quality indicators provides a basis for developing a pharmacist care program in Spanish emergency departments on 3 levels of priority. The list can serve as a guide to pharmacists, managers, physicians, and nurses involved in the effort to improve drug therapy in this hospital setting.
    MeSH term(s) Humans ; Pharmacists ; Consensus ; Pharmacy Service, Hospital ; Emergency Service, Hospital ; Emergency Medicine ; Hospitals
    Language English
    Publishing date 2023-06-23
    Publishing country Spain
    Document type Journal Article
    ZDB-ID 2127173-2
    ISSN 2386-5857 ; 2386-5857
    ISSN (online) 2386-5857
    ISSN 2386-5857
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  9. Article: Respuesta molecular con terapia triple en pacientes con leucemia mieloide crónica.

    López-Arroyo, José Luis / Rico-Ramos, Héctor Joel / Portillo-García, Mireya Leticia

    Revista medica del Instituto Mexicano del Seguro Social

    2014  Volume 52, Issue 3, Page(s) 262–265

    Abstract: Background: Chronic myeloid leukemia is a myeloproliferative disorder which results from the translocation t(9;22)(q34;q11). Imatinib mesylate is an inhibitor of kinase tyrosine that has proved to be useful in patients with chronic myeloid leukemia. Our ...

    Title translation Molecular response with triple therapy in patients with chronic myeloid leukemia.
    Abstract Background: Chronic myeloid leukemia is a myeloproliferative disorder which results from the translocation t(9;22)(q34;q11). Imatinib mesylate is an inhibitor of kinase tyrosine that has proved to be useful in patients with chronic myeloid leukemia. Our aim was to evaluate the major molecular response to 12 months with triple therapy, analyze the evolution of these patients, and the hematological and non-hematological toxicity.
    Methods: It was performed a longitudinal study in patients with diagnosis of chronic myeloid leukemia who were treated with sequential triple therapy: Pegylated interferon alpha 2a (90 μg/week for four weeks) + imatinib (800 mg a day for 30 days) + cytarabine (20 mg/m2 from day 1 to 10). Molecular and hematologic responses at 12 months of treatment were analyzed.
    Results: Thirty eight patients with chronic myeloid leukemia were eligible; the mean age was 43.4 years and the medians of hemoglobin levels, leukocyte and platelet counts at diagnosis were 10 g/dL (5.1 to 16.0 g/dL), 208 000/μL3 (10 600 to 529 000/μL3) and 573 500/μL3 (130 000 to 4 272 000/μL3), respectively. According to the Sokal score, 68.4 % had low risk, 26.3 % intermediate and 5.3 % high risk.
    Conclusions: The hematologic response was similar to that reported in the IRIS study, but the molecular response was greater in more cases. The adverse hematological effects grades 3-4 and non-hematological were significative: 45 % and 87 %, which forces to continous monitoring. The combination of interferon alpha 2a, cytarabine and a high-dose of imatinib induced the major molecular response, of 68.4 %, at 12 months.
    MeSH term(s) Adolescent ; Adult ; Aged ; Antineoplastic Agents/administration & dosage ; Benzamides/administration & dosage ; Cytarabine/administration & dosage ; Drug Therapy, Combination ; Female ; Humans ; Imatinib Mesylate ; Interferon-alpha/administration & dosage ; Leukemia, Myelogenous, Chronic, BCR-ABL Positive/blood ; Leukemia, Myelogenous, Chronic, BCR-ABL Positive/drug therapy ; Leukemia, Myelogenous, Chronic, BCR-ABL Positive/genetics ; Longitudinal Studies ; Male ; Middle Aged ; Piperazines/administration & dosage ; Polyethylene Glycols/administration & dosage ; Pyrimidines/administration & dosage ; Recombinant Proteins/administration & dosage ; Treatment Outcome ; Young Adult
    Chemical Substances Antineoplastic Agents ; Benzamides ; Interferon-alpha ; Piperazines ; Pyrimidines ; Recombinant Proteins ; Cytarabine (04079A1RDZ) ; Polyethylene Glycols (30IQX730WE) ; Imatinib Mesylate (8A1O1M485B) ; peginterferon alfa-2a (Q46947FE7K)
    Language Spanish
    Publishing date 2014-05
    Publishing country Mexico
    Document type Journal Article ; Observational Study
    ZDB-ID 732133-8
    ISSN 0443-5117 ; 0484-7849
    ISSN 0443-5117 ; 0484-7849
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  10. Article ; Online: Tranexamic acid versus aminocapróic acid in multiple doses via the oral route for the reduction of postoperative bleeding in total primary hip arthroplasty: a prospective, randomized, double-blind, controlled study.

    Morales-Avalos, Rodolfo / Ramos-Morales, Tomas / García-Pedro, Jesús A / Espinoza-Galindo, Ana M / Acosta-Olivo, Carlos / Morcos-Sandino, Michelle / Silva-Ramos, Héctor N G / Peña-Martínez, Víctor M / Rodríguez-Torres, Raymundo A / Vilchez-Cavazos, Félix

    Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis

    2020  Volume 32, Issue 2, Page(s) 132–139

    Abstract: To compare the effects of oral ε-aminocaproic acid (EACA) as a hemostatic agent versus the use of oral tranexamic acid (TXA) administered in multiple doses pre and postsurgery in patients undergoing elective primary total hip arthroplasty (THA). We ... ...

    Abstract To compare the effects of oral ε-aminocaproic acid (EACA) as a hemostatic agent versus the use of oral tranexamic acid (TXA) administered in multiple doses pre and postsurgery in patients undergoing elective primary total hip arthroplasty (THA). We enrolled 102 patients that were randomly divided into two groups: received three oral doses of EACA (2000 mg per dose) or three oral doses of TXA (1300 mg per dose). The medication was given according to the following schedule: 2 h before surgery and 6 and 12 h after surgery. The variables analyzed to compare the effectiveness of the hemostatic agents were total blood loss, hidden blood loss, external blood loss, transfusion rate, intraoperative blood loss, decreases in hemoglobin and hematocrit values, surgical drainage output, visual analog scale, and surgical complications. There were no significant differences between any of the study variables for the group receiving oral TXA and the group receiving oral EACA (P > 0.05). Our study showed that the use of oral EACA was similar to its counterpart TXA regarding the evaluated parameters. TXA did not have superior blood conservation effects, safety profile, or differences in functional scales compared with EACA in THA. We consider the use of multiple oral doses of aminocaproic acid at the selected dose to be effective as a standard protocol to achieve less blood loss and a lower rate of transfusion and adverse events related to the medication in patients undergoing a THA.
    MeSH term(s) Administration, Oral ; Aged ; Aminocaproic Acid/administration & dosage ; Aminocaproic Acid/therapeutic use ; Antifibrinolytic Agents/adverse effects ; Antifibrinolytic Agents/therapeutic use ; Arthroplasty, Replacement, Hip/adverse effects ; Double-Blind Method ; Female ; Humans ; Male ; Middle Aged ; Postoperative Hemorrhage/drug therapy ; Postoperative Hemorrhage/etiology ; Prospective Studies ; Tranexamic Acid/administration & dosage ; Tranexamic Acid/therapeutic use ; Treatment Outcome
    Chemical Substances Antifibrinolytic Agents ; Tranexamic Acid (6T84R30KC1) ; Aminocaproic Acid (U6F3787206)
    Language English
    Publishing date 2020-12-21
    Publishing country England
    Document type Journal Article ; Randomized Controlled Trial
    ZDB-ID 1033551-1
    ISSN 1473-5733 ; 0957-5235
    ISSN (online) 1473-5733
    ISSN 0957-5235
    DOI 10.1097/MBC.0000000000001005
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

To top